糖尿病中的载脂蛋白A-1：受损物质。 - Suppr

ApoA-1 in diabetes: damaged goods.

作者信息

Ory Daniel S, Schaffer Jean E

机构信息

Department of Medicine, Washington University School of Medicine, Diabetic Cardiovascular Disease Center, St Louis, Missouri, USA.

出版信息

Diabetes. 2010 Oct;59(10):2358-9. doi: 10.2337/db10-1040.

DOI:10.2337/db10-1040

PMID:20876728

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279547/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6378/3279547/616c6a252799/zdb0101063220001.jpg

相似文献

ApoA-1 in diabetes: damaged goods.

Diabetes. 2010 Oct;59(10):2358-9. doi: 10.2337/db10-1040.

Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1192-200. doi: 10.1161/ATVBAHA.110.222000. Epub 2011 Feb 17.

High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Mol Cell Biochem. 2000 Jun;209(1-2):131-44. doi: 10.1023/a:1007111830472.

High-Density Lipoproteins and Apolipoprotein A1.

Subcell Biochem. 2020;94:399-420. doi: 10.1007/978-3-030-41769-7_16.

Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.

Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):200-210. doi: 10.1016/j.bbadis.2016.10.010. Epub 2016 Oct 18.

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.

Circulation. 2013 Nov 26;128(22):2364-71. doi: 10.1161/CIRCULATIONAHA.113.001551. Epub 2013 Oct 29.

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ-HDL, α-HDL, and triglyceride-rich lipoproteins.

Sci Rep. 2020 Sep 24;10(1):15585. doi: 10.1038/s41598-020-72323-w.

Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

J Lipid Res. 2009 Jun;50(6):1209-15. doi: 10.1194/jlr.P800040-JLR200. Epub 2009 Jan 22.

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I.

Arterioscler Thromb. 1993 Sep;13(9):1299-306. doi: 10.1161/01.atv.13.9.1299.

Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.

J Biol Chem. 2012 Feb 24;287(9):6375-86. doi: 10.1074/jbc.M111.337345. Epub 2012 Jan 4.

引用本文的文献

Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice.

Am J Physiol Endocrinol Metab. 2022 Dec 1;323(6):E480-E491. doi: 10.1152/ajpendo.00158.2022. Epub 2022 Oct 12.

Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring.

J Diabetes Metab Disord. 2021 Mar 29;20(1):611-620. doi: 10.1007/s40200-021-00788-1. eCollection 2021 Jun.

Rapid degradation of ABCA1 protein following cAMP withdrawal and treatment with PKA inhibitor suggests ABCA1 is a short-lived protein primarily regulated at the transcriptional level.

J Diabetes Metab Disord. 2020 Mar 19;19(1):363-371. doi: 10.1007/s40200-020-00517-0. eCollection 2020 Jun.

Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

PLoS One. 2018 Oct 4;13(10):e0204841. doi: 10.1371/journal.pone.0204841. eCollection 2018.

Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.

J Biol Chem. 2012 Feb 24;287(9):6375-86. doi: 10.1074/jbc.M111.337345. Epub 2012 Jan 4.

本文引用的文献

Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes.

Diabetes. 2010 Oct;59(10):2366-74. doi: 10.2337/db10-0371. Epub 2010 Jul 9.

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.

J Biol Chem. 2010 Jun 11;285(24):18473-84. doi: 10.1074/jbc.M110.118182. Epub 2010 Apr 8.

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export.

J Lipid Res. 2010 Jul;51(7):1849-58. doi: 10.1194/jlr.M004085. Epub 2010 Jan 11.

Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12224-9. doi: 10.1073/pnas.0802025105. Epub 2008 Aug 21.

The in vivo gene expression signature of oxidative stress.

Physiol Genomics. 2008 Jun 12;34(1):112-26. doi: 10.1152/physiolgenomics.00239.2007. Epub 2008 Apr 29.

Laboratory assessment of HDL heterogeneity and function.

Clin Chem. 2008 May;54(5):788-800. doi: 10.1373/clinchem.2007.101923. Epub 2008 Mar 28.

Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.

Nephrol Dial Transplant. 2008 Mar;23(3):927-33. doi: 10.1093/ndt/gfm631. Epub 2007 Dec 8.

Illuminating HDL--is it still a viable therapeutic target?

N Engl J Med. 2007 Nov 22;357(21):2180-3. doi: 10.1056/NEJMe0707210. Epub 2007 Nov 5.

Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.

Diabetes. 2006 Nov;55(11):3099-103. doi: 10.2337/db06-0723.

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.

J Clin Invest. 2006 May;116(5):1435-42. doi: 10.1172/JCI27602.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

ApoA-1 in diabetes: damaged goods.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献